-
1
-
-
0029431672
-
Chronic symmetric symptomatic polyneuropathy in the elderly: A field screening investigation in two Italian regions I. Prevalence and general characteristics of the sample
-
Italian General Practitioner Study Group (IGPSG).
-
Italian General Practitioner Study Group (IGPSG). Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology. 1995;45(10):1832-1836.
-
(1995)
Neurology
, vol.45
, Issue.10
, pp. 1832-1836
-
-
-
2
-
-
84907416004
-
Recent advances in transthyretin amyloidosis therapy
-
Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener. 2014;3:19.
-
(2014)
Transl Neurodegener
, vol.3
, pp. 19
-
-
Ueda, M.1
Ando, Y.2
-
3
-
-
22844447647
-
Transthyretin-related familial amyloidotic polyneuropathy
-
Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol. 2005;62(7):1057-1062.
-
(2005)
Arch Neurol
, vol.62
, Issue.7
, pp. 1057-1062
-
-
Ando, Y.1
Nakamura, M.2
Araki, S.3
-
5
-
-
0030004644
-
The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid
-
Lai Z, Colón W, Kelly JW. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry. 1996;35(20):6470-6482.
-
(1996)
Biochemistry
, vol.35
, Issue.20
, pp. 6470-6482
-
-
Lai, Z.1
Colón, W.2
Kelly, J.W.3
-
6
-
-
84914125201
-
Current and future treatment of amyloid neuropathies
-
Adams D, Cauquil C, Theaudin M, et al. Current and future treatment of amyloid neuropathies. Expert Rev Neurother. 2014;14(12):1437-1451.
-
(2014)
Expert Rev Neurother
, vol.14
, Issue.12
, pp. 1437-1451
-
-
Adams, D.1
Cauquil, C.2
Theaudin, M.3
-
7
-
-
0029431672
-
Chronic symmetric symptomatic polyneuropathy in the elderly: A field screening investigation in two Italian regions I. Prevalence and general characteristics of the sample
-
Italian General Practitioner Study Group (IGPSG)
-
Italian General Practitioner Study Group (IGPSG). Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology. 1995;45(10):1832-1836.
-
(1995)
Neurology
, vol.45
, Issue.10
, pp. 1832-1836
-
-
-
8
-
-
84907416004
-
Recent advances in transthyretin amyloidosis therapy
-
Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener. 2014;3:19.
-
(2014)
Transl Neurodegener
, vol.3
, pp. 19
-
-
Ueda, M.1
Ando, Y.2
-
9
-
-
22844447647
-
Transthyretin-related familial amyloidotic polyneuropathy
-
Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol. 2005;62(7):1057-1062.
-
(2005)
Arch Neurol
, vol.62
, Issue.7
, pp. 1057-1062
-
-
Ando, Y.1
Nakamura, M.2
Araki, S.3
-
11
-
-
0030004644
-
The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid
-
Lai Z, Colón W, Kelly JW. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry. 1996;35(20):6470-6482.
-
(1996)
Biochemistry
, vol.35
, Issue.20
, pp. 6470-6482
-
-
Lai, Z.1
Colón, W.2
Kelly, J.W.3
-
12
-
-
84914125201
-
Current and future treatment of amyloid neuropathies
-
Adams D, Cauquil C, Theaudin M, et al. Current and future treatment of amyloid neuropathies. Expert Rev Neurother. 2014;14(12):1437-1451.
-
(2014)
Expert Rev Neurother
, vol.14
, Issue.12
, pp. 1437-1451
-
-
Adams, D.1
Cauquil, C.2
Theaudin, M.3
-
13
-
-
84873979913
-
Guideline of transthyretin-related hereditary amyloidosis for clinicians
-
Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.
-
(2013)
Orphanet J Rare Dis
, vol.8
, pp. 31
-
-
Ando, Y.1
Coelho, T.2
Berk, J.L.3
-
14
-
-
6944240027
-
Liver transplantation in transthyretin-related familial amyloid polyneuropathy
-
Stangou AJ, Hawkins PN. Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr Opin Neurol. 2004;17(5):615-620.
-
(2004)
Curr Opin Neurol
, vol.17
, Issue.5
, pp. 615-620
-
-
Stangou, A.J.1
Hawkins, P.N.2
-
15
-
-
79959936896
-
Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)
-
Wilczek HE, Larsson M, Ericzon BG, et al. Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR). Amyloid. 2011;18(Suppl 1):193-195.
-
(2011)
Amyloid
, vol.18
, pp. 193-195
-
-
Wilczek, H.E.1
Larsson, M.2
Ericzon, B.G.3
-
16
-
-
84861451481
-
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy
-
Ackermann EJ, Guo S, Booten S, et al. Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Amyloid. 2012;19 (Suppl 1):43-44.
-
(2012)
Amyloid
, vol.19
, pp. 43-44
-
-
Ackermann, E.J.1
Guo, S.2
Booten, S.3
-
17
-
-
84889238225
-
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
-
Coelho T, Maia LF, da Silva AM, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol. 2013;260(11):2802-2814.
-
(2013)
J Neurol
, vol.260
, Issue.11
, pp. 2802-2814
-
-
Coelho, T.1
Maia, L.F.2
Da Silva, A.M.3
-
18
-
-
84862222705
-
Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
-
Coelho T, Maia LF, Martins da Silva A, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology. 2012;79(8):785-792.
-
(2012)
Neurology
, vol.79
, Issue.8
, pp. 785-792
-
-
Coelho, T.1
Maia, L.F.2
Martins Da Silva, A.3
-
19
-
-
84887402882
-
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy
-
Lozeron P, Théaudin M, Mincheva Z, et al. Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy. Eur J Neurol. 2013;20(12):1539-1545.
-
(2013)
Eur J Neurol
, vol.20
, Issue.12
, pp. 1539-1545
-
-
Lozeron, P.1
Théaudin, M.2
Mincheva, Z.3
-
20
-
-
84890488396
-
Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis
-
Merlini G, Planté-Bordeneuve V, et al. Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis. J Cardiovasc Transl Res. 2013;6(6):1011-1020.
-
(2013)
J Cardiovasc Transl Res
, vol.6
, Issue.6
, pp. 1011-1020
-
-
Merlini, G.1
Planté-Bordeneuve, V.2
-
21
-
-
84890954073
-
Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial
-
Berk JL, Suhr OB, Obici L, et al. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA. 2013;310(24):2658-2667.
-
(2013)
JAMA
, vol.310
, Issue.24
, pp. 2658-2667
-
-
Berk, J.L.1
Suhr, O.B.2
Obici, L.3
-
22
-
-
33646244247
-
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides
-
Benson MD, Kluve-Beckerman B, Zeldenrust SR, et al. Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides. Muscle Nerve. 2006;33 (5):609-618.
-
(2006)
Muscle Nerve
, vol.33
, Issue.5
, pp. 609-618
-
-
Benson, M.D.1
Kluve-Beckerman, B.2
Zeldenrust, S.R.3
-
23
-
-
84883118140
-
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
-
Coelho T, Adams D, Silva A, et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med. 2013;369(9):819-829.
-
(2013)
N Engl J Med
, vol.369
, Issue.9
, pp. 819-829
-
-
Coelho, T.1
Adams, D.2
Silva, A.3
-
24
-
-
78149282151
-
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
-
Bodin K, Ellmerich S, Kahan MC, et al. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature. 2010;468(7320):93-97.
-
(2010)
Nature
, vol.468
, Issue.7320
, pp. 93-97
-
-
Bodin, K.1
Ellmerich, S.2
Kahan, M.C.3
-
25
-
-
0031034253
-
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome
-
Hughes R, Swan A, Cornblath D, et al. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet. 1997;349(9047):225-230.
-
(1997)
Lancet
, vol.349
, Issue.9047
, pp. 225-230
-
-
Hughes, R.1
Swan, A.2
Cornblath, D.3
-
27
-
-
84923049034
-
Optimizing IgG therapy in chronic autoimmune neuropathies: A hypothesis driven approach
-
Berger M, Allen JA. Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach. Muscle Nerve. 2015;51(3):315-326.
-
(2015)
Muscle Nerve
, vol.51
, Issue.3
, pp. 315-326
-
-
Berger, M.1
Allen, J.A.2
-
29
-
-
44949251941
-
Eculizumab prevents anti-ganglioside antibodymediated neuropathy in a murine model
-
Halstead SK, Zitman FM, Humphreys PD, et al. Eculizumab prevents anti-ganglioside antibodymediated neuropathy in a murine model. Brain. 2008;131(Pt 5):1197-1208.
-
(2008)
Brain
, vol.131
, pp. 1197-1208
-
-
Halstead, S.K.1
Zitman, F.M.2
Humphreys, P.D.3
-
30
-
-
84930199161
-
Treatment of chronic inflammatory demyelinating polyneuropathy
-
Kleyman I, Brannagan TH. Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Neurol Neurosci Rep. 2015;15(7):47.
-
(2015)
Curr Neurol Neurosci Rep
, vol.15
, Issue.7
, pp. 47
-
-
Kleyman, I.1
Brannagan, T.H.2
-
31
-
-
16544372731
-
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
-
Mehndiratta MM, Hughes RA, Pritchard J. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015;8: CD003906.
-
(2015)
Cochrane Database Syst Rev
, vol.8
, pp. CD003906
-
-
Mehndiratta, M.M.1
Hughes, R.A.2
Pritchard, J.3
-
32
-
-
77649176429
-
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision
-
Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. Eur J Neurol. 2010;17(3):356-363.
-
(2010)
Eur J Neurol
, vol.17
, Issue.3
, pp. 356-363
-
-
Van Den Bergh, P.Y.1
Hadden, R.D.2
Bouche, P.3
-
33
-
-
70249146129
-
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
-
Eftimov F, Winer JB, Vermeulen M, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2009;1:CD001797.
-
(2009)
Cochrane Database Syst Rev
, vol.1
, pp. CD001797
-
-
Eftimov, F.1
Winer, J.B.2
Vermeulen, M.3
-
34
-
-
84861189500
-
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: A randomised controlled trial
-
Nobile-Orazio E, Cocito D, Jann S, et al. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol. 2012;11(6):493-502.
-
(2012)
Lancet Neurol
, vol.11
, Issue.6
, pp. 493-502
-
-
Nobile-Orazio, E.1
Cocito, D.2
Jann, S.3
-
35
-
-
0019463420
-
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
-
Imbach P, Barandun S, d'Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981;1(8232):1228-1231.
-
(1981)
Lancet
, vol.1
, Issue.8232
, pp. 1228-1231
-
-
Imbach, P.1
Barandun, S.2
D'Apuzzo, V.3
-
36
-
-
79954600098
-
Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies
-
Berger M, Rojavin M, Kiessling P, et al. Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies. Clin Immunol. 2011;139(2):133-141.
-
(2011)
Clin Immunol
, vol.139
, Issue.2
, pp. 133-141
-
-
Berger, M.1
Rojavin, M.2
Kiessling, P.3
-
37
-
-
84879200850
-
Bioavailability of IgG administered by the subcutaneous route
-
Berger M, Jolles S, Orange JS, et al. Bioavailability of IgG administered by the subcutaneous route. J Clin Immunol. 2013;33(5):984-990.
-
(2013)
J Clin Immunol
, vol.33
, Issue.5
, pp. 984-990
-
-
Berger, M.1
Jolles, S.2
Orange, J.S.3
-
38
-
-
85011864681
-
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy
-
Hughes RA, Mehndiratta MM. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015;1:CD002062.
-
(2015)
Cochrane Database Syst Rev
, vol.1
, pp. CD002062
-
-
Hughes, R.A.1
Mehndiratta, M.M.2
-
39
-
-
84939251115
-
Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP
-
Nobile-Orazio E, Cocito D, Jann S, et al. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP. J Neurol Neurosurg Psychiatry. 2015;86(7):729-734.
-
(2015)
J Neurol Neurosurg Psychiatry
, vol.86
, Issue.7
, pp. 729-734
-
-
Nobile-Orazio, E.1
Cocito, D.2
Jann, S.3
-
40
-
-
84940788734
-
A retrospective study on the efficacy and safety of intraveinous immunoglobulin (Tegeline()) in patients with chronic inflammatory demyelinating polyneuropathy
-
Robert F, Edan G, Nicolas G, et al. A retrospective study on the efficacy and safety of intraveinous immunoglobulin (Tegeline()) in patients with chronic inflammatory demyelinating polyneuropathy. Presse Med. 2015;44(7-8):e291-e300.
-
(2015)
Presse Med
, vol.44
, Issue.7-8
, pp. e291-e300
-
-
Robert, F.1
Edan, G.2
Nicolas, G.3
-
41
-
-
74549226510
-
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy
-
Cocito D, Paolasso I, Antonini G, et al. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2010;17(2):289-294.
-
(2010)
Eur J Neurol
, vol.17
, Issue.2
, pp. 289-294
-
-
Cocito, D.1
Paolasso, I.2
Antonini, G.3
-
42
-
-
84905164148
-
Treatment of multifocal motor neuropathy with intravenous immunoglobulin
-
Koski CL. Treatment of multifocal motor neuropathy with intravenous immunoglobulin. J Clin Immunol. 2014;34 (Suppl 1):S127-S131.
-
(2014)
J Clin Immunol
, vol.34
, pp. S127-S131
-
-
Koski, C.L.1
-
43
-
-
84921031301
-
Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: Improved tolerability and patient satisfaction
-
Hadden RD, Marreno F. Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction. Ther Adv Neurol Disord. 2015;8(1):14-19.
-
(2015)
Ther Adv Neurol Disord
, vol.8
, Issue.1
, pp. 14-19
-
-
Hadden, R.D.1
Marreno, F.2
-
44
-
-
84932142511
-
Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders
-
Yoon MS, Gold R, Kerasnoudis A. Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders. Ther Adv Neurol Disord. 2015;8(4):153-159.
-
(2015)
Ther Adv Neurol Disord
, vol.8
, Issue.4
, pp. 153-159
-
-
Yoon, M.S.1
Gold, R.2
Kerasnoudis, A.3
-
45
-
-
33746454655
-
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy
-
van Schaik IN, Bouche P, Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol. 2006;13(8):802-808.
-
(2006)
Eur J Neurol
, vol.13
, Issue.8
, pp. 802-808
-
-
Van Schaik, I.N.1
Bouche, P.2
Illa, I.3
-
46
-
-
0027417176
-
Multifocal motor neuropathy: Response to human immune globulin
-
Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol. 1993;33(3):237-242.
-
(1993)
Ann Neurol
, vol.33
, Issue.3
, pp. 237-242
-
-
Chaudhry, V.1
Corse, A.M.2
Cornblath, D.R.3
-
48
-
-
0034659131
-
Anti-sulfatide IgM antibodies in peripheral neuropathy
-
Carpo M, Meucci N, Allaria S, et al. Anti-sulfatide IgM antibodies in peripheral neuropathy. J Neurol Sci. 2000;176(2):144-150.
-
(2000)
J Neurol Sci
, vol.176
, Issue.2
, pp. 144-150
-
-
Carpo, M.1
Meucci, N.2
Allaria, S.3
-
49
-
-
0023927923
-
Treatment of patients with neuropathy and anti-MAG IgM M-proteins
-
Nobile-Orazio E, Baldini L, Barbieri S, et al. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol. 1988;24(1):93-97.
-
(1988)
Ann Neurol
, vol.24
, Issue.1
, pp. 93-97
-
-
Nobile-Orazio, E.1
Baldini, L.2
Barbieri, S.3
-
50
-
-
0028102447
-
Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy
-
Nobile-Orazio E, Manfredini E, Carpo M, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol. 1994;36(3):416-424.
-
(1994)
Ann Neurol
, vol.36
, Issue.3
, pp. 416-424
-
-
Nobile-Orazio, E.1
Manfredini, E.2
Carpo, M.3
-
51
-
-
84864526040
-
Immunotherapy for IgM antimyelin-associated glycoprotein paraprotein-associated peripheral neuropathies
-
Lunn MP, Nobile-Orazio E. Immunotherapy for IgM antimyelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev. 2012;5:CD002827.
-
(2012)
Cochrane Database Syst Rev
, vol.5
, pp. CD002827
-
-
Lunn, M.P.1
Nobile-Orazio, E.2
-
52
-
-
84942198795
-
POEMS syndrome: Update on diagnosis, risk-stratification, and management
-
Dispenzieri A. POEMS syndrome: Update on diagnosis, risk-stratification, and management. Am J Hematol. 2015;90(10):951-962.
-
(2015)
Am J Hematol
, vol.90
, Issue.10
, pp. 951-962
-
-
Dispenzieri, A.1
-
53
-
-
84876174288
-
New advances in the diagnosis and treatment of POEMS syndrome
-
Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol. 2013;161 (3):303-315.
-
(2013)
Br J Haematol
, vol.161
, Issue.3
, pp. 303-315
-
-
Li, J.1
Zhou, D.B.2
-
54
-
-
84873049728
-
Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome
-
Kuwabara S, Dispenzieri A, Arimura K, et al. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database Syst Rev. 2012;6:CD006828.
-
(2012)
Cochrane Database Syst Rev
, vol.6
, pp. CD006828
-
-
Kuwabara, S.1
Dispenzieri, A.2
Arimura, K.3
-
56
-
-
0041308236
-
Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology
-
Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26(2):491-494.
-
(2003)
Diabetes Care
, vol.26
, Issue.2
, pp. 491-494
-
-
Moulik, P.K.1
Mtonga, R.2
Gill, G.V.3
-
57
-
-
20144389536
-
Diabetic neuropathies: A statement by the American Diabetes Association
-
Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956-962.
-
(2005)
Diabetes Care
, vol.28
, Issue.4
, pp. 956-962
-
-
Boulton, A.J.1
Vinik, A.I.2
Arezzo, J.C.3
-
58
-
-
84860818001
-
Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K
-
Abbott CA, Malik RA, van Ross ER, et al. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34(10):2220-2224.
-
(2011)
Diabetes Care
, vol.34
, Issue.10
, pp. 2220-2224
-
-
Abbott, C.A.1
Malik, R.A.2
Van Ross, E.R.3
-
59
-
-
62349139024
-
Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: The MONICA/KORA Augsburg Surveys S2 and S3
-
Ziegler D, Rathmann W, Dickhaus T, et al. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med. 2009;10(2):393-400.
-
(2009)
Pain Med
, vol.10
, Issue.2
, pp. 393-400
-
-
Ziegler, D.1
Rathmann, W.2
Dickhaus, T.3
-
60
-
-
0029994187
-
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM complications study
-
Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia. 1996;39(11):1377-1384.
-
(1996)
Diabetologia
, vol.39
, Issue.11
, pp. 1377-1384
-
-
Tesfaye, S.1
Stevens, L.K.2
Stephenson, J.M.3
-
62
-
-
84969413170
-
-
http://www.who.int/diabetes/facts/world-figures
-
-
-
-
63
-
-
84861111124
-
Diabetic neuropathy: Clinical manifestations and current treatments
-
Callaghan BC, Cheng HT, Stables CL, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521-534.
-
(2012)
Lancet Neurol
, vol.11
, Issue.6
, pp. 521-534
-
-
Callaghan, B.C.1
Cheng, H.T.2
Stables, C.L.3
-
64
-
-
84902708889
-
Diabetic neuropathy: Mechanisms, emerging treatments, and subtypes
-
Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep. 2014;14(8):473.
-
(2014)
Curr Neurol Neurosci Rep
, vol.14
, Issue.8
, pp. 473
-
-
Albers, J.W.1
Pop-Busui, R.2
-
65
-
-
84929353718
-
Critical appraisal of international guidelines for the management of diabetic neuropathy: Is there global agreement in the internet era?
-
Sun M, Zhang M, Shen J, et al. Critical appraisal of international guidelines for the management of diabetic neuropathy: is there global agreement in the internet era? Int J Endocrinol. 2015;2015:519032.
-
(2015)
Int J Endocrinol
, vol.2015
, pp. 519032
-
-
Sun, M.1
Zhang, M.2
Shen, J.3
-
66
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group
-
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
-
(1993)
N Engl J Med
, vol.329
, Issue.14
, pp. 977-986
-
-
-
67
-
-
84866324862
-
Enhanced glucose control for preventing and treating diabetic neuropathy
-
Callaghan BC, Little AA, Feldman EL, et al. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;6:CD007543.
-
(2012)
Cochrane Database Syst Rev
, vol.6
, pp. CD007543
-
-
Callaghan, B.C.1
Little, A.A.2
Feldman, E.L.3
-
68
-
-
84901212150
-
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
-
Fullerton B, Jeitler K, Seitz M, et al. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014;2: CD009122.
-
(2014)
Cochrane Database Syst Rev
, vol.2
, pp. CD009122
-
-
Fullerton, B.1
Jeitler, K.2
Seitz, M.3
-
69
-
-
79960959816
-
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: Meta-analysis of randomised controlled trials
-
Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ. 2011;343:d4169.
-
(2011)
BMJ
, vol.343
, pp. d4169
-
-
Boussageon, R.1
Bejan-Angoulvant, T.2
Saadatian-Elahi, M.3
-
70
-
-
84893708965
-
Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy
-
Snedecor SJ, Sudharshan L, Cappelleri JC, et al. Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract. 2014;14(2):167-184.
-
(2014)
Pain Pract
, vol.14
, Issue.2
, pp. 167-184
-
-
Snedecor, S.J.1
Sudharshan, L.2
Cappelleri, J.C.3
-
71
-
-
84879967614
-
Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: A randomised controlled trial
-
Pop-Busui R, Stevens MJ, Raffel DM, et al. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia. 2013;56(8):1835-1844.
-
(2013)
Diabetologia
, vol.56
, Issue.8
, pp. 1835-1844
-
-
Pop-Busui, R.1
Stevens, M.J.2
Raffel, D.M.3
-
72
-
-
84910627065
-
Efficacy of ?-lipoic acid in diabetic neuropathy
-
Papanas N, Ziegler D. Efficacy of ?-lipoic acid in diabetic neuropathy. Expert Opin Pharmacother. 2014;15 (18):2721-2731.
-
(2014)
Expert Opin Pharmacother
, vol.15
, Issue.18
, pp. 2721-2731
-
-
Papanas, N.1
Ziegler, D.2
-
73
-
-
68149106189
-
Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients
-
Ziegler D, Movsesyan L, Mankovsky B, et al. Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients. Diabetes Care. 2009;32(8):1479-1484.
-
(2009)
Diabetes Care
, vol.32
, Issue.8
, pp. 1479-1484
-
-
Ziegler, D.1
Movsesyan, L.2
Mankovsky, B.3
-
74
-
-
33846075220
-
C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
-
Ekberg K, Brismar T, Johansson BL, et al. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care. 2007;30(1):71-76.
-
(2007)
Diabetes Care
, vol.30
, Issue.1
, pp. 71-76
-
-
Ekberg, K.1
Brismar, T.2
Johansson, B.L.3
-
75
-
-
42449127541
-
Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes
-
Ekberg K, Johansson BL. Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes. Exp Diabetes Res. 2008;2008:457912.
-
(2008)
Exp Diabetes Res
, vol.2008
, pp. 457912
-
-
Ekberg, K.1
Johansson, B.L.2
-
76
-
-
83155180436
-
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: The delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial
-
Ruggenenti P, Lauria G, Iliev IP, et al. Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension. 2011;58(5):776-783.
-
(2011)
Hypertension
, vol.58
, Issue.5
, pp. 776-783
-
-
Ruggenenti, P.1
Lauria, G.2
Iliev, I.P.3
-
77
-
-
77953823105
-
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
-
Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88.
-
(2010)
Eur J Neurol
, vol.17
, Issue.9
, pp. e1113-e1188
-
-
Attal, N.1
Cruccu, G.2
Baron, R.3
-
78
-
-
58649121268
-
Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: Discrepancies between direct and indirect meta-analyses of randomized controlled trials
-
Chou R, Carson S, Chan BK. Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials. J Gen Intern Med. 2009;24(2):178-188.
-
(2009)
J Gen Intern Med
, vol.24
, Issue.2
, pp. 178-188
-
-
Chou, R.1
Carson, S.2
Chan, B.K.3
-
80
-
-
79957500607
-
Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation
-
Bril V, England J, Franklin GM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76(20):1758-1765.
-
(2011)
Neurology
, vol.76
, Issue.20
, pp. 1758-1765
-
-
Bril, V.1
England, J.2
Franklin, G.M.3
-
81
-
-
84868008289
-
Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention
-
Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncology. 2012;14(SUPPL.4):iv45-iv54.
-
(2012)
Neuro-Oncology
, vol.14
, pp. iv45-iv54
-
-
Grisold, W.1
Cavaletti, G.2
Windebank, A.J.3
-
82
-
-
84905454673
-
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline
-
Hershman DL, Lacchetti C, Dworkin RH, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941-1967.
-
(2014)
J Clin Oncol
, vol.32
, Issue.18
, pp. 1941-1967
-
-
Hershman, D.L.1
Lacchetti, C.2
Dworkin, R.H.3
-
83
-
-
84907424832
-
Interventions for preventing neuropathy caused by cisplatin and related compounds
-
Albers JW, Chaudhry V, Cavaletti G, et al. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev. 2014;3:CD005228.
-
(2014)
Cochrane Database Syst Rev
, vol.3
, pp. CD005228
-
-
Albers, J.W.1
Chaudhry, V.2
Cavaletti, G.3
-
84
-
-
79953012566
-
Interventions for preventing neuropathy caused by cisplatin and related compounds
-
Albers JW, Chaudhry V, Cavaletti G, et al. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev. 2011;2: CD005228.
-
(2011)
Cochrane Database Syst Rev
, vol.2
, pp. CD005228
-
-
Albers, J.W.1
Chaudhry, V.2
Cavaletti, G.3
-
85
-
-
39049123158
-
Interventions for preventing neuropathy caused by cisplatin and related compounds
-
Albers J, Chaudhry V, Cavaletti G, et al. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev. 2007;1: CD005228.
-
(2007)
Cochrane Database Syst Rev
, vol.1
, pp. CD005228
-
-
Albers, J.1
Chaudhry, V.2
Cavaletti, G.3
-
86
-
-
84945452920
-
Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy
-
Ben-Arye E, Samuels N, Schiff E, et al. Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy. Support Care Cancer. 2015;23(12):3411-3419.
-
(2015)
Support Care Cancer
, vol.23
, Issue.12
, pp. 3411-3419
-
-
Ben-Arye, E.1
Samuels, N.2
Schiff, E.3
-
87
-
-
84931087350
-
Treatment-related symptom management in patients with multiple myeloma: A review
-
Colson K. Treatment-related symptom management in patients with multiple myeloma: a review. Support Care Cancer. 2015;23(5):1431-1445.
-
(2015)
Support Care Cancer
, vol.23
, Issue.5
, pp. 1431-1445
-
-
Colson, K.1
-
88
-
-
84928810867
-
Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives
-
Ewertz M, Qvortrup C, Eckhoff L. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol. 2015;54(5):587-591.
-
(2015)
Acta Oncol
, vol.54
, Issue.5
, pp. 587-591
-
-
Ewertz, M.1
Qvortrup, C.2
Eckhoff, L.3
-
89
-
-
84939262907
-
Chemotherapyinduced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry
-
Mols F, Beijers AJ, Vreugdenhil G, et al. Chemotherapyinduced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry. J Cancer Surviv. 2015;9(3):512-522.
-
(2015)
J Cancer Surviv
, vol.9
, Issue.3
, pp. 512-522
-
-
Mols, F.1
Beijers, A.J.2
Vreugdenhil, G.3
-
90
-
-
78649906324
-
Chemotherapy-induced peripheral neurotoxicity
-
Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol. 2010;6(12):657-666.
-
(2010)
Nat Rev Neurol
, vol.6
, Issue.12
, pp. 657-666
-
-
Cavaletti, G.1
Marmiroli, P.2
-
91
-
-
84858799716
-
Chemotherapyinduced peripheral neurotoxicity (CIPN): An update
-
Argyriou AA, Bruna J, Marmiroli P, et al. Chemotherapyinduced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol. 2012;82(1):51-77.
-
(2012)
Crit Rev Oncol Hematol
, vol.82
, Issue.1
, pp. 51-77
-
-
Argyriou, A.A.1
Bruna, J.2
Marmiroli, P.3
-
92
-
-
0345060438
-
Paclitaxel and cisplatin-induced neurotoxicity: A protective role of acetyl-L-carnitine
-
Pisano C, Pratesi G, Laccabue D, et al. Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res. 2003;9(15):5756-5767.
-
(2003)
Clin Cancer Res
, vol.9
, Issue.15
, pp. 5756-5767
-
-
Pisano, C.1
Pratesi, G.2
Laccabue, D.3
-
93
-
-
84927610343
-
Platinum-induced neurotoxicity and preventive strategies: Past, present, and future
-
Avan A, Postma TJ, Ceresa C, et al. Platinum-induced neurotoxicity and preventive strategies: past, present, and future. Oncologist. 2015;20(4):411-432.
-
(2015)
Oncologist
, vol.20
, Issue.4
, pp. 411-432
-
-
Avan, A.1
Postma, T.J.2
Ceresa, C.3
-
94
-
-
52949143529
-
Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy
-
Amara S. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy. Ann Pharmacother. 2008;42(10):1481-1485.
-
(2008)
Ann Pharmacother
, vol.42
, Issue.10
, pp. 1481-1485
-
-
Amara, S.1
-
96
-
-
84919361240
-
Chemotherapyinduced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models
-
Carozzi VA, Chiorazzi A, Canta A, et al. Chemotherapyinduced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models. Exp Neurol. 2015;264:92-102.
-
(2015)
Exp Neurol
, vol.264
, pp. 92-102
-
-
Carozzi, V.A.1
Chiorazzi, A.2
Canta, A.3
-
97
-
-
84870851045
-
The fundamental role of morphology in experimental neurotoxicology: The example of chemotherapy-induced peripheral neurotoxicity
-
Marmiroli P, Nicolini G, Miloso M, et al. The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity. Ital J Anat Embryol. 2012;117(2):75-97.
-
(2012)
Ital J Anat Embryol
, vol.117
, Issue.2
, pp. 75-97
-
-
Marmiroli, P.1
Nicolini, G.2
Miloso, M.3
-
98
-
-
42649115088
-
Neurotoxic effects of antineoplastic drugs: The lesson of pre-clinical studies
-
Cavaletti G, Nicolini G, Marmiroli P. Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies. Front Biosci. 2008;13:3506-3524.
-
(2008)
Front Biosci
, vol.13
, pp. 3506-3524
-
-
Cavaletti, G.1
Nicolini, G.2
Marmiroli, P.3
-
99
-
-
0033675496
-
Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: Clinicopathological, neurophysiological, and immunological study
-
Cavaletti G, Matà S, Fasano A, et al. Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: clinicopathological, neurophysiological, and immunological study. J Neurosci Res. 2000;62(5): 709-716.
-
(2000)
J Neurosci Res
, vol.62
, Issue.5
, pp. 709-716
-
-
Cavaletti, G.1
Matà, S.2
Fasano, A.3
-
100
-
-
84878692548
-
Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): A University of Rochester CCOP study
-
Gewandter JS, Fan L, Magnuson A, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013;21 (7):2059-2066.
-
(2013)
Support Care Cancer
, vol.21
, Issue.7
, pp. 2059-2066
-
-
Gewandter, J.S.1
Fan, L.2
Magnuson, A.3
-
101
-
-
0028035097
-
Postural instability in patients with diabetic sensory neuropathy
-
Simoneau GG, Ulbrecht JS, Derr JA, et al. Postural instability in patients with diabetic sensory neuropathy. Diabetes Care. 1994;17(12):1411-1421.
-
(1994)
Diabetes Care
, vol.17
, Issue.12
, pp. 1411-1421
-
-
Simoneau, G.G.1
Ulbrecht, J.S.2
Derr, J.A.3
|